(Q74238074)
Statements
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment (English)
T A Davis
A J Grillo-López
C A White
P McLaughlin
M S Czuczman
D G Maloney
R L Weaver
J Rosenberg
1 September 2000